PHARMACY

Watson enters marketing agreement with GeneraMedix

BY Alaric DeArment

MORRISTOWN, N.J. Watson Pharmaceuticals has entered an exclusive U.S. marketing agreement with a generic drug maker for its branded anemia drug.

Watson, which mostly manufactures generics, announced Tuesday that it had granted GeneraMedix a license for a generic version of the injected drug Ferrlecit (sodium ferric gluconate complex in sucrose). Under the agreement, GeneraMedix, which has filed an approval application with the Food and Drug Administration for generic Ferrlecit, will supply its version to Watson, which will market, sell and distribute it in the United States. Terms of the agreement were not disclosed.

Watson markets branded Ferrlecit under a supply and distribution agreement with Sanofi-Aventis. The product rights for Ferrlecit will return to Sanofi on Dec. 31.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Food industry vets commence new lobbying practice

BY Allison Cerra

WASHINGTON Policy Solutions, a new government and public affairs firm, has opened a practice in Washington, led by three food industry veterans.

The new firm will provide strategic advice to its clients and assistance in coalition building, grassroots program development, media relations, and in community outreach and corporate responsibility programs.

The three principals of the lobbying group include John Motley, former SVP government affairs for the Food Marketing Institute; Barry Scher, former long-time VP public affairs for Giant Foods; and Jay Truitt, former VP government affairs for the National Cattlemen’s Beef Association. 

“With both a new Congress and administration, there will be increased legislative and regulatory activity. Policy Solution’s principals have an extensive experience in working with both Congress and the Executive Branch on a wide range of policy issues, from food safety to energy and from taxes to health care,” said Motley.

For more information on this group, visit policy-solutions.net.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Wegmans seeks to reduce paper usage for prescriptions

BY Michael Johnsen

ROCHESTER, N.Y. Wegmans’ SVP of consumer affairs Mary Ellen Burris on Sunday noted that Wegmans pharmacies are losing a significant amount of paper weight in her weekly online blog.

Wegmans pharmacies are eliminating pharmacy prescription information sheets for all refills, she noted, which would more or less result in 10 million fewer printouts each year.

“That’s the scoop on … you know, the enclosure with every single prescription that you probably don’t even read while you’re throwing it away,” she wrote. “Now, there are some you should read … a first time prescription, for instance. However, after you understand the precautions, use, side effects, drug interactions and storage (my favorite, for a recently prescribed drug: “do not store in the bathroom” which is where I keep all medical stuff) … such information is typically not really needed for refills.”

Completing implementation of new pharmacy software made it possible, Burris noted, making pharmacy prescription information sheets for refills, which consist of about 50% of the prescriptions filled at Wegmans, obsolete.

Essential information is still printed with each prescription filled, however.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?